MiR-7 promotes epithelial cell transformation by targeting the tumor suppressor KLF4

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Meza Sosa, Karla F ^a   Pérez García, Erick I ^a   Camacho Concha, Nohemí ^a   López Gutiérrez, Oswaldo ^a   Pedraza Alva, Gustavo ^a   Pérez Martínez, Leonor ^a  

^a INSTITUTO DE BIOTECNOLOGÍA   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D; KRUPPEL LIKE FACTOR 4; MICRORNA; MICRORNA 7; PROTEIN P21; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; CYCLIN DEPENDENT KINASE INHIBITOR 1A; KRUPPEL LIKE FACTOR; MIRN7 MICRORNA, HUMAN; PROTEIN BINDING;

3' UNTRANSLATED REGION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BINDING SITE; CARCINOGENESIS; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CELL TRANSFORMATION; CONTROLLED STUDY; EPITHELIUM CELL; GENE OVEREXPRESSION; GENETIC CONSERVATION; IN VITRO STUDY; IN VIVO STUDY; MALE; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PREDICTION; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN RNA BINDING; PROTEIN TARGETING; SIGNAL TRANSDUCTION; TUMOR GROWTH; ANIMAL; CELL CYCLE S PHASE; CELL MOTION; DOWN REGULATION; DRUG SCREENING; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; MOLECULAR EVOLUTION; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; NUDE MOUSE; PATHOLOGY; TUMOR CELL LINE;

3' UNTRANSLATED REGIONS; ANIMALS; BASE SEQUENCE; BINDING SITES; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; CONSERVED SEQUENCE; CYCLIN D; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DOWN-REGULATION; EPITHELIAL CELLS; EVOLUTION, MOLECULAR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MALE; MICE, NUDE; MICRORNAS; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; S PHASE; TUMOR STEM CELL ASSAY;

EID: 84929505331     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0103987     Document Type: Article

References (86)

1. Mahatan CS, Kaestner KH, Geiman DE, Yang VW (1999) Characterization of the structure and regulation of the murine gene encoding gut-enriched Krüppellike factor (Krüppel-like factor 4). Nucleic Acids Res 27: 4562-4569.
2. Segre JA, Bauer C, Fuchs E (1999) Klf4 is a transcription factor required for establishing the barrier function of the skin. Nature 22: 356-360. (Pubitemid 29369526)
3. Chiambaretta F, De Graeve F, Turet G, Marceau G, Gain P, et al. (2004) Cell and tissue specific expression of human Krüppel-like transcription factors in human ocular surface. Mol Vis 10: 901-909. (Pubitemid 41358202)
4. Shields J, Christy R, Yang V (1996) Identification and characterization of a gene encoding a gut-enriched Krüppel-like factor expressed during growth arrest. J Biol Chem 271: 20009-20017.
5. Dang D, Pevsner J, Yang V (2009) The biology of the mammalian Krüppel-like family of transcription factors. Int J Biochem 32: 1103-1121.
6. Li H, Han M, Bernier M, Zheng B, Sun S, et al. (2010) Krüppel-like Factor 4 Promotes Differentiation by Transforming Growth Factor-beta Receptor-mediated Smad and p38 MAPK Signaling in Vascular Smooth Muscle Cells. J Biol Chem 285: 17846-17856. doi:10.1074/jbc.M109.076992.
7. Katz JP, Perreault N, Goldstein BG, Actman L, Nally SRMC, et al. (2005) Loss of Klf4 in Mice Causes Altered Proliferation and Differentiation and Precancerous Changes in the Adult Stomach. Gastroenterology 128: 935-945. doi:10.1053/j.gastro.2005.02.022. (Pubitemid 40523545)
8. Katz JP, Perreault N, Goldstein BG, Lee CS, Labosky PA, et al. (2002) The zincfinger transcription factor Klf4 is required for terminal differentiation of goblet cells in the colon. Development 129: 2619-2628. (Pubitemid 34874246)
9. Yoshida T, Gan Q, Franke AS, Ho R, Zhang J, et al. (2010) Smooth and Cardiac Muscle-selective Knock-out of Krüppel-like Factor 4 Causes Postnatal Death and Growth Retardation. J Biol Chem 285: 21175-21184. doi:10.1074/jbc.M110.112482.
10. Evans PM, Liu C (2008) Roles of Krüppel-like factor 4 in normal homeostasis, cancer and stem cells. Acta Biochim Biophys Sin (Shanghai) 40: 554-564. doi:10.1111/j.1745-7270.2008.00439.x. (Pubitemid 352009081)
11. McConnell B, Ghaleb A, Nandan M, Yang V (2008) The diverse functions of Krüppel-like factors 4 and 5 in epithelial biology and pathobiology. Cancer 29: 549-557. (Pubitemid 46903942)
12. Ghaleb AM, Nandan MO, Chanchevalap S, Brian W, Hisamuddin IM, et al. (2005) Krüppel-like factors 4 and 5: the yin and yang regulators of cellular proliferation. Cell Res 15: 92-96. (Pubitemid 41653948)
13. Shie J, Pestell R, TC C (1999) Repression of the Cyclin D1 promoter by Gut-Enriched Kruppel-like Factor. Gastroenterology 11: A520.
14. Shie J, Chen Z, Fu M, Pestell R, Tseng C (2000) Gut-enriched Kruppel-like factor represses cyclin D1 promoter activity through Sp1 motif. Nucleic Acids Res 28: 2969-2976. (Pubitemid 30599273)
15. Nickenig G, Baudler S, Müller C, Werner C, Werner N, et al. (2002) Redoxsensitive vascular smooth muscle cell proliferation is mediated by GKLF and Id3 in vitro and in vivo. FASEB J 16: 1077-1086. (Pubitemid 34753514)
16. Zhang W, Geiman D, Shields J, Dang D, Mahatan C, et al. (2000) The gut enriched Kruppel-like factor (Kruppel-like factor 4) mediates the transactivating effect of p53 on the p21WAF1/Cip1 promoter. J Biol Chem 275: 18391-18398. (Pubitemid 30414796)
17. Yasunaga J, Taniguchi Y, Nosaka K, Yoshida M, Satou Y, et al. (2004) Identification of aberrantly methylated genes in association with adult T-cell leukemia. Cancer Res 64: 6002-6009. (Pubitemid 39129397)
18. Kharas M, Yusuf I, Scarfone V, Yang V, Segre J, et al. (2007) KLF4 suppresses transformation of pre-B cells by ABL oncogenes. Blood 109: 747-755. (Pubitemid 46105977)
19. Wei D, Gong W, Kanai M, Schlunk C, Wang L, et al. (2005) Drastic down-regulation of Kruppel-like factor 4 expression is critical in human gastric cancer development and progression. Cancer Res 65: 2746-2754. (Pubitemid 40490076)
20. Ghaleb A, McConnell B, Nandan M, Katz J, Kaestner K, et al. (2007) Haploinsufficiency of Kruppel-like factor 4 promotes adenomatous polyposis coli dependent intestinal tumorigenesis. Cancer Res 67: 7147-7154. (Pubitemid 47206542)
21. Luo A, Kong J, Hu G, Liew C, Xiong M, et al. (2004) Discovery of Ca2+- relevant and differentiation-associated genes downregulated in esophageal squamous cell carcinoma using cDNA microarray. Oncogene 23: 1291-1299. (Pubitemid 38297184)
22. Wang N, Liu Z, Ding F, Wang X, Zhou C, et al. (2002) Down-regulation of gutenriched Kruppel-like factor expression in esophageal cancer. World J Gastroenterol 8: 966-970. (Pubitemid 35446403)
23. Ohnishi S, Ohnami S, Laub F, Aoki K, Suzuki K, et al. (2003) Downregulation and growth inhibitory effect of epithelial-type Kruppel-like transcription factor KLF4, but not KLF5, in bladder cancer. Biochem Biophys Res Commun 308: 251-256. (Pubitemid 36937173)
24. Bianchi F, Hu J, Pelosi G, Cirincione R, Ferguson M, et al. (2004) Lung cancers detected by screening with spiral computed tomography have a malignant phenotype when analyzed by cDNA microarray. Clin Cancer Res 10: 6023-6028. (Pubitemid 39287506)
25. Li J, Zheng H, Yu F, Yu T, Liu C, et al. (2012) Deficiency of the Kruppel-like factor KLF4 correlates with increased cell proliferation and enhanced skin tumorigenesis. Carcinogenesis 33: 1239-1246. doi:10.1093/carcin/ bgs143.
26. Foster K, Frost A, McKie-Bell P, Li C, Engler J, et al. (2000) Increase of GKLF messenger RNA and protein expression during progression of breast cancer. Cancer Res 60: 6488-6495.
27. Cao X, Yeo G, Muotri AR, Kuwabara T, Gage FH (2006) Noncoding RNAs in the mammalian central nervous system. Annu Rev Neurosci 29: 77-103. doi:10.1146/annurev.neuro.29.051605.112839. (Pubitemid 44476840)
28. Olsen PH, Ambros V (1999) The lin-4 regulatory RNA controls developmental timing in Caenorhabditis elegans by blocking LIN-14 protein synthesis after the initiation of translation. Dev Biol 216: 671-680. doi:10.1006/dbio.1999.9523. (Pubitemid 30013313)
29. Meza-Sosa K, Valle-García D, Pedraza-Alva G, Pérez- Martínez L (2012) Role of microRNAs in central nervous system development and pathology. J Neurosci Res 90: 1-12. doi:10.1002/jnr.22701.
30. Strauss WM, Chen C, Lee C-T, Ridzon D (2006) Nonrestrictive developmental regulation of microRNA gene expression. Mamm Genome 17: 833-840. doi:10.1007/s00335-006-0025-7. (Pubitemid 44232580)
31. Klein ME, Impey S, Goodman RH (2005) Role reversal: the regulation of neuronal gene expression by microRNAs. Curr Opin Neurobiol 15: 507-513. doi:10.1016/j.conb.2005.08.011. (Pubitemid 41394394)
32. Zhao X, He X, Han X, Yu Y, Ye F, et al. (2010) MicroRNA-mediated control of oligodendrocyte differentiation. Neuron 65: 612-626. doi:10.1016/j.neuron. 2010.02.018.
33. Li X, Jin P (2010) Roles of small regulatory RNAs in determining neuronal identity. Nat Rev Neurosci 11: 329-338. doi:10.1038/nrn2739.
34. Lu J, Getz G, Miska E a, Alvarez-Saavedra E, Lamb J, et al. (2005) MicroRNA expression profiles classify human cancers. Nature 435: 834-838. doi:10.1038/nature03702. (Pubitemid 40839735)
35. Tian Y, Luo A, Cai Y, Su Q, Ding F, et al. (2010) MicroRNA-10b Promotes Migration and Invasion through KLF4 in Human Esophageal Cancer Cell Lines. J Biol Chem 285: 7986-7994. doi:10.1074/jbc.M109.062877.
36. Parasramka MA, Dashwood M, Wang R, Saeed HH, Williams DE, et al. (2012) A role for low-abundance miRNAs in colon cancer: the miR-206/Krüppel-like factor 4 (KLF4) axis. Clin Epigenetics 4: 1-10. doi:10.1186/1868-7083-4-16.
37. Chen H-Y, Yu-Min L, Chung H-C, Lang Y-D, Ching-Jung L, et al. (2012) miR- 103/107 Promote Metastasis of Colorectal Cancer by Targeting the Metastasis Suppressors DAPK and KLF4. Cancer Res 72: 3631-3641.
38. Okuda H, Xing F, Pandey PR (2013) miR-7 Suppresses Brain Metastasis of Breast Cancer Stem-Like Cells By Modulating KLF4. Cancer Res 73: 1434-1444. doi:10.1158/0008-5472.CAN-12-2037.
39. Chou Y, Lin H, Lien Y, Repressor T (2010) EGFR Promotes Lung Tumorigenesis by Activating miR-7 through a Ras/ERK/Myc Pathway That Targets the Ets2 Transcriptional Repressor ERF EGFR Promotes Lung Tumorigenesis by Activating miR-7. Cancer Res 70: 8822-8831. doi:10.1158/0008-5472.CAN-10-0638.
40. Yu Z, Ni L, Chen D, Zhang Q, Su Z, et al. (2013) Identification of miR-7 as an oncogene in renal cell carcinoma. J Mol Histol. doi:10.1007/s10735-013- 9516-5.
41. Sun S, Zheng B, Han M, Fang X, Li H, et al. (2010) miR-146a and Krüppel-like factor 4 form a feedback loop to participate in vascular smooth muscle cell proliferation. Nature 12: 56-62. doi:10.1038/embor.2010.172.
42. Xie C, Huang H, Sun X, Guo Y, Hamblin M, et al. (2010) MicroRNA-1 Regulates Smooth Muscle Cell Differentiation by Repressing Kruppel-Like Factor 4. Stem Cells Dev 20: 1-6. doi:10.1089/scd.2010.0283.
43. Xu N, Papagiannakopoulos T, Pan G, Thomson J a, Kosik KS (2009) MicroRNA-145 regulates OCT4, SOX2, and KLF4 and represses pluripotency in human embryonic stem cells. Cell 137: 647-658. doi:10.1016/j.cell.2009.02.038.
44. Kertesz M, Iovino N, Unnerstall U, Gaul U, Segal E (2007) The role of site accessibility in microRNA target recognition. Nat Genet 39: 1278-1284. doi:10.1038/ng2135. (Pubitemid 47482690)
45. Rehmsmeier M, Steffen P, Hochsmann M, Giegerich R (2004) Fast and effective prediction of microRNA/target duplexes. RNA 10: 1507-1517. doi:10.1261/rna.5248604. (Pubitemid 39288185)
46. Lewis BP, Shih I, Jones-rhoades MW, Bartel DP, Burge CB (2003) Prediction of Mammalian MicroRNA Targets. Cell 115: 787-798. (Pubitemid 38058492)
47. John B, Enright AJ, Aravin A, Tuschl T, Sander C, et al. (2004) Human MicroRNA targets. PLoS Biol 2: e363. doi:10.1371/journal.pbio.0020363.
48. Rhodes N, Innes CL, Propst F, Paules RS (1997) Serum starved v-mostransformed cells are unable to appropriately downregulate cyclins and CDKs. Oncogene 14: 3017-3027. doi:10.1038/sj.onc.1201158. (Pubitemid 27336317)
49. Hanahan D, Weinberg RA (2011) Review Hallmarks of Cancer: The Next Generation. Cell 144: 646-674. doi:10.1016/j.cell.2011.02.013.
50. Chen C-Z, Li L, Lodish HF, Bartel DP (2004) MicroRNAs modulate hematopoietic lineage differentiation. Science (80-) 303: 83-86. doi:10.1126/science.1091903.
51. Ivey KN, Srivastava D (2010) MicroRNAs as Regulators of Differentiation and Cell Fate Decisions. Cell Stem Cell 7: 36-41. doi:10.1016/j.stem.2010.06. 012.
52. Ambros V (2004) The functions of animal microRNAs. Nature 431: 350-355.
53. Tsitsiou E, Lindsay MA (2009) microRNAs and the immune response. Curr Opin Pharmacol 9: 514-520.
54. Sengupta S, Nie J, Wagner RJ, Yang C, Stewart R, et al. (2009) MicroRNA 92b controls the G1/S checkpoint gene p57 in human embryonic stem cells. Stem Cells 27: 1524-1528. doi:10.1002/stem.84.
55. Wang X, Liu P, Zhu H, Xu Y, Ma C, et al. (2009) miR-34a, a microRNA upregulated in a double transgenic mouse model of Alzheimer's disease, inhibits bcl2 translation. Brain Res 80: 268-273. doi:10.1016/j.brainresbull.2009.08.006.
56. De Smaele E, Ferretti E, Gulino A (2010) MiRNAs as biomarkers for CNS cancer and other disorders. Brain Res 1338: 100-111. doi:10.1016/j.brainres. 2010.03.103.
57. Luo L, Ye G, Nadeem L, Fu G, Yang BB, et al. (2012) MicroRNA-378a-5p promotes trophoblast cell survival, migration and invasion by targeting Nodal. J Cell Sci 125: 3124-3132. doi:10.1242/jcs.096412.
58. Lee JM, Yoo JK, Yoo H (2013) The Novel miR-7515 Decreases the Proliferation and Migration of Human Lung Cancer Cells by Targeting c-Met. Mol Cancer Res 11: 43-53. doi:10.1158/1541-7786.MCR-12-0355.
59. Zhang W, Chen X, Kato Y, Evans P, Yuan S, et al. (2006) Krüppel-like factor 4 and b-catenin regulates normal intestinal homeostasis and tumor repression. Mol Cell Biol 26: 2055-2064. (Pubitemid 43346910)
60. Kaldis P, Pagano M (2009) Wnt signaling in mitosis. Dev Cell 17: 749-750. doi:10.1016/j.devcel.2009.12.001.
61. Fang Y, Davies PF (2012) Site-specific microRNA-92a regulation of Krüppellike factors 4 and 2 in atherosusceptible endothelium. Arterioscler Thromb Vasc Biol 32: 979-987. doi:10.1161/ATVBAHA.111.244053.
62. Yori JL, Johnson E, Zhou G, Jain MK, Keri RA (2010) Kruppel-like factor 4 inhibits epithelial-to-mesenchymal transition through regulation of E-cadherin gene expression. J Biol Chem 285: 16854-16863. doi:10.1074/jbc.M110.114546.
63. Lieber M, Smith B, Szakal A, Nelson-Rees W, Todaro G (1976) A continuous tumor-cell line from a human lung carcinoma with properties of type II alveolar epithelial cells. Int J Cancer 17: 62-70.
64. Deyrieux A, Wilson V (2007) In vitro culture conditions to study keratinocyte differentiation using the HaCaT cell line. Cytotechnology 54: 77-83. doi:10.1007/s10616-007-9076-1. (Pubitemid 47174819)
65. Yoon H, Yang V (2004) Requirement of Krüppel-like factor 4 in preventing entry into mitosis following DNA damage. J Biol Chem 279: 5035-5041. (Pubitemid 38199100)
66. Yoon H, Ghaleb A, Nandan M, Hisamuddin I, Dalton W, et al. (2005) Krüppellike factor 4 prevents centrosome amplification following gamma-irradiationinduced DNA damage. Oncogene 24: 4017-4025. (Pubitemid 40897049)
67. Ky N, Lim C, Li J, Tam J, Hamza M, et al. (2009) KLF4 suppresses HDACi induced caspase activation and the SAPK pathway by targeting p57(Kip2). Apoptosis 14: 1095-1107.
68. Johnson DG, Walker CL (1999) Cyclins and cell cycle checkpoints. Annu Rev Pharmacol Toxicol 39: 295-312. doi:10.1146/annurev.pharmtox.39.1.295. (Pubitemid 29222561)
69. Zhang Y, Chen B, Ding Y (2012) Metastasis-associated Factors Facilitating the Progression of Colorectal Cancer. Asian Pacific J Cancer Prev 13: 2437-2444.
70. Mohan N, Ai W, Chakrabarti M, Banik NL, Ray SK (2013) KLF4 overexpression and apigenin treatment down regulated anti-apoptotic Bcl-2 proteins and matrix metalloproteinases to control growth of human malignant neuroblastoma SK-N-DZ and IMR-32 cells. Mol Oncol 7: 464-474. doi:10.1016/j.molonc.2012.12.002.
71. Lin Z-S, Chu H-C, Yen Y-C, Lewis BC, Chen Y-W (2012) Krüppel-like factor 4, a tumor suppressor in hepatocellular carcinoma cells reverts epithelial mesenchymal transition by suppressing slug expression. PLoS One 7: e43593. doi:10.1371/journal.pone.0043593.
72. Yu F, Li J, Chen H, Fu J, Ray S, et al. (2011) Kruppel-like factor 4 (KLF4) is required for maintenance of breast cancer stem cells and for cell migration and invasion. Oncogene 30: 2161-2172. doi:10.1038/onc.2010.591.
73. Sanchez N, Gallagher M, Lao N, Gallagher C, Clarke C, et al. (2013)MiR-7 Triggers Cell Cycle Arrest at the G1/S Transition by Targeting Multiple Genes Including Skp2 and Psme3. PLoS One 8: e65671. doi:10.1371/journal.pone.0065671.
74. Xiong S, Zheng Y, Jiang P, Liu R, Liu X, et al. (2011) MicroRNA-7 inhibits the growth of human non-small cell lung cancer A549 cells through targeting BCL-2. Int J Biol Sci 7: 805-814.
75. Hawryluk E, Baran J, Gerami P, Sepehr A (2013) "Monster cell" melanoma with pulmonary metastasis and cyclin D1 amplification. J Cutan Pathol 40: 61-65.
76. Komatsu S, Ichikawa D, Tsujiura M, Konishi H, Takeshita H, et al. (2013) Prognostic impact of circulating miR-21 in the plasma of patients with gastric carcinoma. Anticancer Res 33: 271-276.
77. Griffiths-Jones S, Grocock RJ, van Dongen S, Bateman A, Enright AJ (2006) miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res 34: D140-D144. doi:10.1093/nar/gkj112.
78. Hubbard T, Barker D, Birney E, Cameron G, Chen Y, et al. (2002) The Ensembl genome database project. Nucleic Acids Res 30: 38-41. (Pubitemid 34679498)
79. Krek A, Grün D, Poy MN, Wolf R, Rosenberg L, et al. (2005) Combinatorial microRNA target predictions. Nat Genet 37: 495-500. doi:10.1038/ng1536. (Pubitemid 40617277)
80. Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159. doi:10.1006/abio.1987.9999. (Pubitemid 17064313)
81. Varkonyi-Gasic E, Wu R, Wood M, Walton EF, Hellens RP (2007) Protocol: a highly sensitive RT-PCR method for detection and quantification of microRNAs. Plant Methods 3: 1-12. doi:10.1186/1746-4811-3-12.
82. Pallante P, Visone R, Ferracin M, Ferraro A, Berlingieri MT, et al. (2006) MicroRNA deregulation in human thyroid papillary carcinomas. Endocr Relat Cancer 13: 497-508. doi:10.1677/erc.1.01209. (Pubitemid 43886672)
83. Rozen S, Skaletsky H (2000) Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol 132: 365-386.
84. Marshall O (2004) PerlPrimer: cross-platform, graphical primer design for standard, bisulphite and real-time PCR. Bioinformatics 20: 2471-2472.
85. Pérez-Martínez L, Jaworski DM (2005) Tissue inhibitor of metalloproteinase-2 promotes neuronal differentiation by acting as an anti-mitogenic signal. J Neurosci 25: 4917-4929. doi:10.1523/JNEUROSCI.5066-04. 2005. (Pubitemid 40712835)
86. Camacho-Concha N, Olivos-Ortiz A, Nuñez-Rivera A, Pedroza-Saavedra A, Gutierrez-Xicotencatl L, et al. (2013) CD43 promotes cells transformation by preventing merlin-mediated contact inhibition of growth. PLoS One 8.